{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:32:58Z","timestamp":1791120778601,"version":"4.1.0"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The incidence of invasive fungal infection (IFI) is increasing, especially among patients diagnosed with hematological malignancies due to their immunocompromised nature. Other risk factors include advanced age, exposure to immunosuppressants, neutropenia, and catheter use. Some of the most common IFI organisms reported are Candida and Aspergillus species, and other fungal species, including Scedosporium, Trichosporon, Cryptococcus, and Fusarium have also increasingly been reported in the past years. However, the epidemiologic data on IFI among patients with hematological malignancies in Asian countries are lacking. Therefore, we investigated published epidemiologic data on such cases from the past 10 years (2011\u20132021) and discuss the challenges faced in the diagnosis and management of IFIs in Asia.<\/jats:p>","DOI":"10.1093\/epirev\/mxae003","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T13:16:13Z","timestamp":1716210973000},"page":"1-12","source":"Crossref","is-referenced-by-count":8,"title":["A review of the epidemiology of invasive fungal infections in Asian patients with hematological malignancies (2011\u20132021)"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-620X","authenticated-orcid":false,"given":"Thevambiga","family":"Iyadorai","sequence":"first","affiliation":[{"name":"University of Malaya Department of Medical Microbiology, Faculty of Medicine, , 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Tee","family":"Tay","sequence":"additional","affiliation":[{"name":"University of Malaya Department of Medical Microbiology, Faculty of Medicine, , 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Chiat","family":"Liong","sequence":"additional","affiliation":[{"name":"University of Malaya Department of Medicine, Faculty of Medicine, , 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandramathi","family":"Samudi","sequence":"additional","affiliation":[{"name":"University of Malaya Department of Medical Microbiology, Faculty of Medicine, , 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Chee","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Haematology, Hospital Ampang , 68000 Ampang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Sum","family":"Cheong","sequence":"additional","affiliation":[{"name":"University of Malaya Department of Medicine, Faculty of Medicine, , 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukumani","family":"Velayuthan","sequence":"additional","affiliation":[{"name":"University of Malaya Department of Medical Microbiology, Faculty of Medicine, , 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen Mui","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Haematology, Hospital Ampang , 68000 Ampang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin Gin","family":"Gan","sequence":"additional","affiliation":[{"name":"University of Malaya Department of Medicine, Faculty of Medicine, , 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"2024091717030945300_ref1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001-2010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2024091717030945300_ref2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/clinids\/27.5.1138","article-title":"The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance","volume":"27","author":"Rees","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2024091717030945300_ref3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jof4010038","article-title":"Estimation of the burden of serious human fungal infections in Malaysia","volume":"4","author":"Velayuthan","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"2024091717030945300_ref4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024091717030945300_ref5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"2024091717030945300_ref6","first-page":"195","article-title":"Opportunistic invasive fungal infections: diagnosis & clinical management","volume":"139","author":"Badiee","year":"2014","journal-title":"Indian J Med Res"},{"key":"2024091717030945300_ref7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"2024091717030945300_ref8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.idc.2010.01.002","article-title":"Fungal infections in transplant and oncology patients","volume":"24","author":"Person","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"2024091717030945300_ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.2000.02014.x","article-title":"Towards a targeted, risk-based, antifungal strategy in neutropenic patients","volume":"110","author":"Prentice","year":"2000","journal-title":"Br J Haematol"},{"key":"2024091717030945300_ref10","first-page":"85","article-title":"Invasive fungal infections in transplant recipients","volume":"1","author":"Vazquez","year":"2013","journal-title":"Ther Adv Infect Dis"},{"key":"2024091717030945300_ref11","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024091717030945300_ref12","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1007\/s00520-019-04720-5","article-title":"High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes","volume":"27","author":"Nganthavee","year":"2019","journal-title":"Support Care Cancer"},{"key":"2024091717030945300_ref13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National surveillance of fungemia in Denmark (2004 to 2009)","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2024091717030945300_ref14","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review","volume":"14","author":"Falagas","year":"2010","journal-title":"Int J Infect Dis"},{"key":"2024091717030945300_ref15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2334-10-312","article-title":"Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007","volume":"10","author":"Poikonen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2024091717030945300_ref16","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2024091717030945300_ref17","article-title":"High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: a prospective observational study in Taiwan","volume":"10","author":"Tang","year":"2015","journal-title":"PloS One"},{"key":"2024091717030945300_ref18","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41467-019-13164-8","article-title":"A meta-analysis of global fungal distribution reveals climate-driven patterns","volume":"10","author":"V\u011btrovsk\u00fd","year":"2019","journal-title":"Nat Commun"},{"key":"2024091717030945300_ref19","doi-asserted-by":"crossref","first-page":"1104519","DOI":"10.3389\/fcimb.2022.1104519","article-title":"Editorial: tropical fungal diseases","volume":"12","author":"Taborda","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2024091717030945300_ref20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2017","journal-title":"Blood Rev"},{"key":"2024091717030945300_ref21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.13205","article-title":"Epidemiology of invasive fungal disease in haematologic patients","volume":"64","author":"Souza","year":"2021","journal-title":"Mycoses"},{"key":"2024091717030945300_ref22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13277-014-2649-7","article-title":"Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China","volume":"36","author":"Sun","year":"2015","journal-title":"Tumour Biol"},{"key":"2024091717030945300_ref23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jmii.2018.01.002","article-title":"Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical Centre in Taiwan, 2008-2013","volume":"53","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"2024091717030945300_ref24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hemonc.2015.06.006","article-title":"Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India","volume":"8","author":"Dewan","year":"2015","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"2024091717030945300_ref25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","article-title":"Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies","volume":"96","author":"Kurosawa","year":"2012","journal-title":"Int J Hematol"},{"key":"2024091717030945300_ref26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197851","article-title":"Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: a retrospective cohort study","volume":"13","author":"Lien","year":"2018","journal-title":"PloS One"},{"key":"2024091717030945300_ref27","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2147\/IDR.S254478","article-title":"An overview of the management of the most important invasive fungal infections in patients with blood malignancies","volume":"Volume 13","author":"Shariati","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2024091717030945300_ref28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/504490","article-title":"Invasive fungal pathogens: current epidemiological trends","volume":"43","author":"Pfaller","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2024091717030945300_ref29","volume-title":"Candida and Candidiasis","author":"Calderone","year":"2012"},{"key":"2024091717030945300_ref30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options","volume":"62","author":"Sardi","year":"2013","journal-title":"J Med Microbiol"},{"key":"2024091717030945300_ref31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0929-6646(09)60091-7","article-title":"Invasive candidiasis: an overview from Taiwan","volume":"108","author":"Ruan","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"2024091717030945300_ref32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2024091717030945300_ref33","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2024091717030945300_ref34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"key":"2024091717030945300_ref35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","article-title":"Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study","volume":"21","author":"Tan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2024091717030945300_ref36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/jof5030058","article-title":"On the origins of a species: what might explain the rise of Candida auris?","volume":"5","author":"Jackson","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2024091717030945300_ref37","first-page":"ofv163","article-title":"Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008-2014. Open Forum","volume":"2","author":"Vallabhaneni","year":"2015","journal-title":"Infect Dis"},{"key":"2024091717030945300_ref38","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2024091717030945300_ref39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkp507","article-title":"Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006","volume":"65","author":"Hahn-Ast","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2024091717030945300_ref40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.21776","article-title":"Invasive fungal disease in patients treated for newly diagnosed acute leukemia","volume":"85","author":"Hammond","year":"2010","journal-title":"Am J Hematol"},{"key":"2024091717030945300_ref41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijantimicag.2012.07.022","article-title":"Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010","volume":"40","author":"Chen","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"2024091717030945300_ref42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmii.2016.08.011","article-title":"Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan","volume":"51","author":"Lin","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"2024091717030945300_ref43","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.553648","article-title":"A 5-year review of invasive fungal infection at an academic medical center","volume":"10","author":"Li","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2024091717030945300_ref44","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/CMAR.S238166","article-title":"Risk prediction and prognosis of invasive fungal disease in hematological malignancies patients complicated with bloodstream infections","volume":"Volume 12","author":"Xiao","year":"2020","journal-title":"Cancer Manag Res"},{"key":"2024091717030945300_ref45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/mmy\/myx038","article-title":"Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents","volume":"56","author":"Kim","year":"2018","journal-title":"Med Mycol"},{"issue":"4","key":"2024091717030945300_ref46","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01791-16","article-title":"Clinical and microbiological characteristics of breakthrough candidemia in allogeneic hematopoietic stem cell transplant recipients in a Japanese hospital","volume":"61","author":"Kimura","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2024091717030945300_ref47","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pbc.23005","article-title":"Invasive fungal infections in pediatric oncology","volume":"56","author":"Mor","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2024091717030945300_ref48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/tid.12176","article-title":"Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country","volume":"16","author":"Ali","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"2024091717030945300_ref49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/mmy\/myy015","article-title":"Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish pediatric bone marrow transplantation study group","volume":"57","author":"Hazar","year":"2019","journal-title":"Med Mycol"},{"key":"2024091717030945300_ref50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/ijmm.IJMM_15_543","article-title":"Screening of invasive fungal infections by a real-time panfungal (pan-ACF) polymerase chain reaction assay in patients with haematological malignancy","volume":"35","author":"Capoor","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"2024091717030945300_ref51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/myc.12646","article-title":"Invasive fungal infection following chemotherapy for acute myeloid leukaemia\u2013experience from a developing country","volume":"60","author":"Korula","year":"2017","journal-title":"Mycoses"},{"key":"2024091717030945300_ref52","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1099\/jmm.0.027631-0","article-title":"In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur hospital","volume":"60","author":"Amran","year":"2011","journal-title":"Malaysia J Med Microbiol"},{"key":"2024091717030945300_ref53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3855\/jidc.9634","article-title":"Distribution and antifungal susceptibility pattern of Candida species at a tertiary hospital in Malaysia","volume":"12","author":"Mohamed","year":"2018","journal-title":"J Infect Dev Ctries"},{"key":"2024091717030945300_ref54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2024091717030945300_ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3114\/sim.2011.70.01","article-title":"Phylogeny of Penicillium and the segregation of Trichocomaceae into three families","volume":"70","author":"Houbraken","year":"2011","journal-title":"Stud Mycol"},{"key":"2024091717030945300_ref56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1469-0691.2010.03323.x","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species","volume":"17","author":"Alanio","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2024091717030945300_ref57","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/myc.12354","article-title":"Azole-resistant Aspergillus fumigatus isolates carrying TR\u2083\u2084\/L98H mutations in Taiwan","volume":"58","author":"Wu","year":"2015","journal-title":"Mycoses"},{"key":"2024091717030945300_ref58","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","article-title":"The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis","volume":"33","author":"Perfect","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2024091717030945300_ref59","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"2024091717030945300_ref60","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024091717030945300_ref61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4614-4726-9_3","article-title":"Invasive fungal infections in patients with chronic granulomatous disease","volume":"764","author":"Henriet","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"2024091717030945300_ref62","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 6","key":"2024091717030945300_ref63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1469-0691.12513","article-title":"Update on antifungal resistance in Aspergillus and Candida","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2024091717030945300_ref64","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain","volume":"54","author":"Mortensen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2024091717030945300_ref65","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2024091717030945300_ref66","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4ffcf1da-b180-4149-834c-9c723c5dbf9b","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathog"},{"key":"2024091717030945300_ref67","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02023-18","article-title":"Epidemiology and antifungal susceptibility profile of Aspergillus species: comparison between environmental and clinical isolates from patients with hematologic malignancies","volume":"57","author":"Cho","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2024091717030945300_ref68","first-page":"150","article-title":"Clinical features and survival outcomes of invasive aspergillosis in pediatric patients at a medical school in Thailand","volume":"99","author":"Anugulruengkitt","year":"2016","journal-title":"J Med Assoc Thai"},{"key":"2024091717030945300_ref69","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s12098-018-2722-0","article-title":"Prevalence and predictors of invasive fungal infections in children with persistent febrile neutropenia treated for acute leukemia - a prospective study","volume":"85","author":"Kumar","year":"2018","journal-title":"Indian J Pediatr"},{"key":"2024091717030945300_ref70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","author":"Delarze","year":"2015","journal-title":"Drug Resist Updat"},{"key":"2024091717030945300_ref71","author":"Dixon","year":"1996"},{"issue":"Suppl 7","key":"2024091717030945300_ref72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/imj.15588","article-title":"Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021","volume":"51","author":"Teh","year":"2021","journal-title":"Intern Med J"},{"key":"2024091717030945300_ref73","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/myc.13082","article-title":"Treatment of invasive fungal diseases in cancer patients-revised 2019 recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"63","author":"Ruhnke","year":"2020","journal-title":"Mycoses"},{"key":"2024091717030945300_ref74","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/pharmaceutics13091333","article-title":"In vitro interaction and killing-kinetics of amphotericin B combined with anidulafungin or caspofungin against Candida auris","volume":"13","author":"Caballero","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"2024091717030945300_ref75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01563-21","article-title":"Highly conserved gsc1 gene of Pneumocystis jirovecii in patients with or without prior exposure to echinocandins","volume":"66","author":"Bonnet","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2024091717030945300_ref76","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00399-19","article-title":"Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside","volume":"63","author":"Aruanno","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2024091717030945300_ref77","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and other polyenes-Discovery, clinical use, mode of action and drug resistance","volume":"6","author":"Carolus","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2024091717030945300_ref78","first-page":"418","article-title":"Kristanc L, Bo\u017ei\u010d B, Jokhadar SZ, Dolenc MS, Gomi\u0161\u010dek G. The pore-forming action of polyenes","volume":"1861","author":"from model membranes to living organisms","year":"2019","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"2024091717030945300_ref79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2024091717030945300_ref80","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2024091717030945300_ref81","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.061562898","article-title":"Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors","volume":"98","author":"Podust","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024091717030945300_ref82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1439-0507.2009.01766.x","article-title":"Investigation of mutations in Erg11 gene of fluconazole resistant Candida albicans isolates from Turkish hospitals","volume":"54","author":"Manast\u0131r","year":"2011","journal-title":"Mycoses"},{"key":"2024091717030945300_ref83","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/mmy\/myv114","article-title":"Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region","volume":"54","author":"Tan","year":"2016","journal-title":"Med Mycol"},{"key":"2024091717030945300_ref84","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1517\/14656566.2015.1083976","article-title":"Treatment of drug-resistant aspergillus infection","volume":"16","author":"Aigner","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"2024091717030945300_ref85","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2024091717030945300_ref86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijid.2020.01.007","article-title":"Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: an Asia Fungal Working Group (AFWG) survey","volume":"95","author":"Tan","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2024091717030945300_ref87","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1200\/JOP.18.00307","article-title":"Establishing an antifungal program to reduce invasive fungal infections in patients with acute myeloid leukemia receiving induction and reinduction chemotherapy","volume":"14","author":"Morris","year":"2018","journal-title":"J Oncol Pract"},{"key":"2024091717030945300_ref88","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/myc.12728","article-title":"Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: a real-world comparison","volume":"61","author":"Tormo","year":"2018","journal-title":"Mycoses"},{"key":"2024091717030945300_ref89","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s00277-019-03744-5","article-title":"Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis","volume":"98","author":"Rodr\u00edguez-Veiga","year":"2019","journal-title":"Ann Hematol"},{"issue":"511","key":"2024091717030945300_ref90","first-page":"e511","article-title":"Voriconazole in hematopoietic stem cell transplantation and cellular therapies: real-world usage and therapeutic level attainment at a major transplantation center","volume":"28","author":"Lindsay","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2024091717030945300_ref91","first-page":"20499361211043969","article-title":"The burden of serious fungal infections in Azerbaijan","volume":"8","author":"Huseynov","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"2024091717030945300_ref92","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1093\/jac\/dkac251","article-title":"Unmet needs and practical solutions in the management of invasive mould infections in Asia","volume":"77","author":"Chen","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2024091717030945300_ref93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009503","article-title":"Climate change and the emergence of fungal pathogens","volume":"17","author":"Nnadi","year":"2021","journal-title":"PLoS Pathog"},{"key":"2024091717030945300_ref94","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/imj.12064","article-title":"Antifungal drug usage in haematologic patients during a 4-year period in an Asian university teaching hospital","volume":"43","author":"Chan","year":"2013","journal-title":"Intern Med J"},{"issue":"4","key":"2024091717030945300_ref95","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00277-013-1882-2","article-title":"Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients","volume":"93","author":"Chan","year":"2014","journal-title":"Ann Hematol"},{"key":"2024091717030945300_ref96","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/0300060518811472","article-title":"Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment","volume":"47","author":"Wang","year":"2019","journal-title":"J Int Med Res"}],"container-title":["Epidemiologic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/epirev\/advance-article-pdf\/doi\/10.1093\/epirev\/mxae003\/57829435\/mxae003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/epirev\/article-pdf\/46\/1\/1\/59140807\/mxae003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/epirev\/article-pdf\/46\/1\/1\/59140807\/mxae003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:04:51Z","timestamp":1726592691000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/epirev\/article\/46\/1\/1\/7679850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,9,16]]}},"URL":"https:\/\/doi.org\/10.1093\/epirev\/mxae003","relation":{},"ISSN":["1478-6729"],"issn-type":[{"value":"1478-6729","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]}}}